Bovine dialyzable leukocyte extract modulates cytokines and nitric oxide production in lipopolysaccharide-stimulated human blood cells

References

• Parry SL, Sebbag M, Feldmann M, Brennan FM. Contact with T cells modulates monocyte IL-10 production: role of T cell membrane TNF-alpha. J Immunol 1997; 158: 3673–81
   PubMed Web of Science ®Google Scholar
• Baron R. Pathophysiology of septic shock and implications for therapy. J Clin Pharmacol 1993; 12: 8298–306
   Google Scholar
• Kornbluth RS, Edgington TS. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin. J Immunol 1986; 137: 2585–91
   PubMed Web of Science ®Google Scholar
• Wittman M, Larsson VA, Schmidt P, Begemann G, et al. Suppression of interleukin-12 production by human monocytes after preincubation with lipopolysaccharide. Blood 1999; 94: 1717–26
   PubMedGoogle Scholar
• Vacek A, Hofer M, Karel B, et al. Positive effects of dialyzable leukocyte extract (DLE) on recovery of mouse haemopoiesis suppressed by ionizing radiation and on proliferation of haemopoietic progenitor cells in vitro. Int J Immunopharmacol 2000; 22: 623–34
   PubMed Web of Science ®Google Scholar
• Ian S, Jones EC, Usher LR, et al. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J Immunol 2002; 168: 4701–10
   PubMedGoogle Scholar
• Aggarwal BB, Natarajan K. Tumor necrosis factor: developments during the last decade. Eur Cytokine Netw 1996; 7: 93–124
   PubMed Web of Science ®Google Scholar
• Van DP, Malefyt RW, Coyle SM, Lowry SF. Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J Infect Dis 1997; 175: 118–22
   PubMedGoogle Scholar
• Gottlieb AA, Maziarz GA, Tamaki N, Sutcliffe SB. The effects of dialyzable products from human leukocyte extracts on cutaneus delayed-hypersensitivity response. J Immunol 1980; 124: 1123–31
   Google Scholar
• Estrada PS, Nagaya A, Serrano E, et al. Comparative study of transfer factor and acyclovir in the treatment of herpes zoster. Int J Immunopharmacol 1998; 20: 521–35
   PubMedGoogle Scholar
• Franco-Molina MA, Mendoza-Gamboa E, Castillo-León L, et al. Bovine dialyzable leukocyte extract protects against LPS-induced, murine endotoxic shock. Int J Immunopharmacol 2004; 13: 1577–86
   Google Scholar
• Franco-Molina MA, Mendoza-Gamboa E, Castillo-León L, et al. Bovine dialyzable leukocyte extract modulates the nitric oxide and pro-inflammatory cytokine production in lipopolysaccharide-stimulated murine peritoneal macrophages in vitro. J Med Food 2005; 8: 20–6
   PubMed Web of Science ®Google Scholar
• Didier H, Glauser PM, Calandra T. Molecular basis of host–pathogen interaction in septic shock. Curr Op Microbiol 1998; 1: 49–55
   PubMedGoogle Scholar
• Beutler BI, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229: 869–71
   PubMed Web of Science ®Google Scholar
• Dankesreiter S, Hoess A, Schneider MJ, et al. Synthetic endotoxin-binding peptides block endotoxin-triggered TNF-α production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock. J Immunol 2000; 164: 4804–11
   PubMed Web of Science ®Google Scholar
• Zuckerman SH, Evans GF, Snyder YM, Roeder WD. Endotoxin-macrophage interaction: post-translational regulation of tumor necrosis factor expression. J Immunol 1989; 143: 1223–7
   PubMed Web of Science ®Google Scholar
• Lasfargues A, Ledur A, Charon D, et al. Induction by lipopolysaccharide of intracellular and extracellular interleukin-1 production: analysis with synthetic models. J Immunol 1987; 139: 429–36
   PubMedGoogle Scholar
• Lauw NF, Pajkrt D, Hack CE, et al. Proinflammatory effects of IL-10 during human endotoxemia. J Immunol 2000; 165: 2783–9
   PubMed Web of Science ®Google Scholar
• Yoshimoto T, Nakanishi K, Hirose S, et al. High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor. J Immunol 1992; 148: 3596–603
   PubMedGoogle Scholar
• Veltri S, Smith JW. Interleukin 1 trials in cancer patients: a review of the toxicity, antitumor and hematopoietic effects. Stem Cells 1996; 14: 164–76
   PubMed Web of Science ®Google Scholar
• Hawiger J, Veach RA, Liu XY, et al. IκB kinase complex is an intracellular target for endotoxic lipopolysaccharide in human monocytic cells. Blood 1999; 94: 1711–16
   PubMedGoogle Scholar
• Ojeda OM, Fernandez CB, Rosaínz MJ. Dialyzable leukocyte extract (DLE) reduces lipopolysaccharide-induced tumor necrosis factor secretion in human leukocytes. Biother 1996; 9: 163–70
   PubMedGoogle Scholar
• Heinzel FP, Hujer AM, Ahmed FN, Rerko RM. In vivo production and function of IL-12 p40 homodimers. J Immunol 1997; 158: 4381–8
   PubMed Web of Science ®Google Scholar
• Voisin L, Breuillé D, Ruot B, et al. Cytokine modulation by PX differently affects specific acute phase proteins during sepsis in rats. Am J Physiol Reg Int Comp Physiol 1998; 275: 1412–19
   PubMedGoogle Scholar
• Rodríguez BI, Pérez MPY, Jiménez GGA, et al. Uso del factor de transferencia en recién nacidos con choque séptico. Medicina Universitaria 2000; 2: 125–30
   Google Scholar